How can providers, manufacturers, and infection-prevention departments implement this shift without undue strain on their limited time and resources? We explore this issue in a series of posts guiding stakeholders through the process.
As the FDA decides on new recommendations for mitigating infection risk from ERCP procedures, researchers at Indiana University sought to determine if some methods of reprocessing are superior to others. No reprocessing methods eliminate risk of infection.
“A multidisciplinary approach is necessary to optimize clinical resources, decrease associated risk, and improve patient safety associated with the use of flexible endoscopes," the authors of a new study write.